Company profile for Antev

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Antev is a Phase III-ready biopharmaceutical company focused on the development of a robust registration-ready data package in areas of unmet clinical need for men’s health: prostate cancer, acute urinary retention (AUR) and benign prostatic hyperplasia (BPH), and establishing value in women’s health indications: endometriosis and uterine fibroids.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
3rd Floor, 106 New Bond Street, London W1S 1DN
Telephone
Telephone
+44 (0)207 495 3053
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/03/08/2622699/0/en/Antev-Receives-US-FDA-Guidance-on-Teverelix-Phase-3-Trial-Design-for-Treating-Advanced-Prostate-Cancer-Patients-with-Increased-Cardiovascular-Risk.html

GLOBENEWSWIRE
08 Mar 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty